论文部分内容阅读
目的分析拉贝洛尔治疗妊娠高血压的临床疗效及对分娩结局的影响。方法 124例妊娠高血压患者,根据治疗不同方法分为对照组(55例)与观察组(69例)。对照组给予硫酸镁治疗,观察组在对照组基础上加用拉贝洛尔治疗,对比两组血压水平变化及分娩结局情况。结果观察组血压水平控制明显优于对照组(P<0.05),且总不良分娩结局率5.80%低于对照组21.82%(P<0.05)。结论采用拉贝洛尔联合硫酸镁治疗妊娠高血压效果显著,有利于稳定控制血压水平和改善分娩结局。
Objective To analyze the clinical efficacy of labetalol in the treatment of pregnancy-induced hypertension and its effect on delivery outcome. Methods 124 cases of pregnancy-induced hypertension were divided into control group (n = 55) and observation group (n = 69) according to different treatment methods. The control group was treated with magnesium sulfate. The observation group was treated with labetalol on the basis of the control group. The changes of blood pressure level and delivery outcome were compared between the two groups. Results The blood pressure of the observation group was significantly better than that of the control group (P <0.05), and the rate of total adverse delivery was 5.80% lower than that of the control group (21.82%, P <0.05). Conclusion The combination of labetalol and magnesium sulfate has a significant effect on the treatment of pregnancy-induced hypertension, which is beneficial to the stable control of blood pressure and the improvement of delivery outcomes.